GlassScriptPhysician profile
Tammi Williams
NPI 1003876509
$1,583.54
in general payments reported to CMS, 2019-2025
28 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $414 · 2021: $338 · 2022: $110 · 2023: $216 · 2024: $44.71 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $362.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.51 | 2020-2023 | Qulipta, Ubrelvy |
| Mayne Pharma Commercial LLC | $150.08 | 2022-2023 | |
| Coopersurgical, INC. | $149.82 | 2019-2025 | Paragard T 380a |
| Avion Pharmaceuticals | $111.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $110.69 | 2019-2021 | |
| Therapeuticsmd, INC. | $86.23 | 2019-2020 | |
| Applied Medical Resources Corporation | $75.06 | 2022 | |
| Hologic Sales and Service, LLC | $73.68 | 2023-2025 | Aptima |
| Daiichi Sankyo INC. | $65.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $56.76 | 2019-2021 | |
| Lupin INC. | $53.84 | 2019-2021 | |
| Evofem Biosciences, INC. | $47.41 | 2021 | |
| Medicem INC. | $35.23 | 2020-2021 | |
| Duchesnay USA Incorporated | $35.13 | 2019 | |
| Covidien LP | $32.43 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $32.35 | 2019 | |
| Mylan Pharmaceuticals INC. | $28.64 | 2019-2021 | |
| Vertical Pharmaceuticals, LLC | $27.04 | 2019 | |
| Amag Pharmaceuticals, INC. | $24.88 | 2019-2020 | |
| Pfizer INC. | $23.49 | 2019 | |
| Optumhealth Care Solutions, LLC | $20.05 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Terumo Medical Corporation | $15.83 | 2021 | |
| Baxter Healthcare | $15.73 | 2019 | |
| Smith+Nephew, INC. | $15.47 | 2025 | Pico 14, Pico 7 |
| Biohaven Pharmaceuticals, INC. | $14.42 | 2021 | |
| Exeltis, USA INC. | $14.05 | 2021 | |
| Boston Scientific Corporation | $11.69 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammi Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.